Predicting Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer
Conditions: Muscle-Invasive Bladder Carcinoma Interventions: Combination Product: neoadjuvant chemotherapy Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Acupressure for Reducing Anxiety in Patients Undergoing Chemotherapy
Conditions: Hematopoietic and Lymphatic System Neoplasm; Malignant Solid Neoplasm Interventions: Procedure: Acupressure Therapy; Other: Educational Intervention; Other: Electronic Health Record Review; Other: Questionnaire Administration Sponsors: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Carcinoma Interventions: Radiation: SBRT; Radiation: Low-dose Radiotherapy (LDRT); Drug: Toripalimab; Drug: Gemcitabine; Drug: Cisplatin; Radiation: IMRT Sponsors: Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
A Real-world Study of Adebrelimab Combined With Chemotherapy ±Chest Radiotherapy in Patients With Extensive Stage Small Cell Lung Cancer
Conditions: Extensive Stage Small Cell Lung Cancer Interventions: Drug: Adebrelimab + chemotherapy; Radiation: ±chest radiotherapy Sponsors: Hebei Medical University Fourth Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Clinically Node-negative Head and Neck Squamous Cell Carcinoma
Conditions: Head and Neck Squamous Cell Carcinoma Interventions: Drug: Tislelizumab （neoadjuvant）; Drug: Cisplatin （neoadjuvant）; Drug: Nab-paclitaxel （neoadjuvant）; Procedure: Surgical resection; Drug: Cisplatin（adjuvant）; Drug: Tislelizumab（adjuvant）; Radiation: Radiation; Drug: Carboplatin（neoadjuvant）; Drug: Carboplatin（adjuvant） Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
Transcutaneous Electrical Nerve Stimulation (TENS) for Chemotherapy Induced Peripheral Neuropathy (CIPN)
Conditions: Chemotherapy-induced Peripheral Neuropathy; Pain; Neuropathy Interventions: Device: High-Dose TENS; Device: Low-Dose TENS Sponsors: Baylor College of Medicine; NeuroMetrix, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer
Conditions: Endometrial Cancer Interventions: Drug: carboplatin; Drug: Paclitaxel; Drug: Recombinant humanized anti-PD-1 monoclonal antibody injection Sponsors: Bio-Thera Solutions Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Chemotherapy With Cetuximab as Conversion Therapy in RAS/BRAF WT Unresectable Liver Metastasis Right-sided Colon Cancer
Conditions: Colon Cancer Interventions: Drug: Doublet or triplet chemotherapy combined with cetuximab Sponsors: Qilu Hospital of Shandong University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Adebrelimab and a TKI in Combination With GEMOX in First-line Treatment of Advanced Biliary Tract Cancers (BTC)
Conditions: Biliary Tract Cancer; Gemox Chemotherapy Interventions: Drug: Adebrelimab + GEMOX + TKI Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Suzhou Suncadia Biopharmaceuticals Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural Mesothelioma
Conditions: Malignant Pleural Mesothelioma Interventions: Drug: Lenvatinib; Drug: Pemetrexed; Drug: Cisplatin/Carboplatin; Drug: Pembrolizumab Sponsors: Hyogo Medical University; Merck Sharp& Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Conditions: Acute Leukemia of Ambiguous Lineage; B Acute Lymphoblastic Leukemia Interventions: Drug: Asparaginase Erwinia chrysanthemi; Procedure: Biospecimen Collection; Biological: Blinatumomab; Procedure: Bone Marrow Aspiration; Drug: Calaspargase Pegol; Procedure: Computed Tomography; Drug: Cyclophosphamide; Drug: Cytarabine; Drug: Daunorubicin; Drug: Dexamethasone; Drug: Doxorubicin; Procedure: Echocardiography; Procedure: FDG-Positron Emission Tomography; Drug: Leucovorin; Procedure: Lumbar Puncture; Procedure: Magnetic Resonance Imaging; Drug: Mercaptopurine; Drug: Methotrexate; Procedure: Multigated Acquisition Sca...
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
The Effect of Breathing Exercise on Sleep and Stress Levels in Women With Breast Cancer Receiving Chemotherapy Treatment
Conditions: Women Receiving Chemotherapy; 18 Years of Age and Above; Women With High Stress Levels; Women With Poor Sleep Quality Interventions: Other: Breathing exercise Sponsors: University of Yalova Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
Preoperative Inflammatory Markers Predict Postoperative Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Colorectal Carcinomatosis
Conditions: Peritoneal Carcinomatosis Sponsors: CHU de Reims Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma
Conditions: Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type Interventions: Drug: Sintilimab+Pegaspargase; Drug: P-GemOx; Drug: GELAD; Radiation: IMRT Sponsors: Fudan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer
Conditions: Electroacupuncture; Olanzapine-contained Four-drug Antiemetic; Nausea and Vomiting Interventions: Device: Electroacupuncture; Drug: Antiemetic Therapy; Device: Sham electroacupuncture; Drug: Antiemetic Therapy Sponsors: Feixue Song Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
